BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2461601)

  • 1. Differentiation of malignant from normal and reactive mesothelial cells by the argyrophil technique for nucleolar organiser region associated proteins.
    Ayres JG; Crocker JG; Skilbeck NQ
    Thorax; 1988 May; 43(5):366-70. PubMed ID: 2461601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Utility of morphometry and nucleolar organizer regions count in the differentiation of reactive and malignant mesothelial cells in pleural effusions].
    Colecchia M; Agnelli T; Caronni E; Leopardi O
    Pathologica; 1991; 83(1083):89-97. PubMed ID: 1866205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses.
    Wolanski KD; Whitaker D; Shilkin KB; Henderson DW
    Cancer; 1998 Feb; 82(3):583-90. PubMed ID: 9452278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.
    Soosay GN; Griffiths M; Papadaki L; Happerfield L; Bobrow L
    J Pathol; 1991 Apr; 163(4):299-305. PubMed ID: 2033489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study.
    Crocker J; Skilbeck N
    J Clin Pathol; 1987 Aug; 40(8):885-9. PubMed ID: 3654987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma.
    Bethwaite PB; Delahunt B; Holloway LJ; Thornton A
    Pathology; 1995 Jan; 27(1):1-4. PubMed ID: 7603742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrophilic nucleolar organiser region (AgNOR) staining in normal bone marrow cells.
    Nikicicz EP; Norback DH
    J Clin Pathol; 1990 Sep; 43(9):723-7. PubMed ID: 1698824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports.
    King J; Thatcher N; Pickering C; Hasleton P
    Histopathology; 2006 Dec; 49(6):561-8. PubMed ID: 17163840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of AgNOR count in distinguishing benign from malignant mesothelial cells in pleural fluids.
    Colecchia M; Leopardi O
    Pathol Res Pract; 1992 Jun; 188(4-5):541-4. PubMed ID: 1409085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
    Cury PM; Butcher DN; Corrin B; Nicholson AG
    J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organiser regions in small cell carcinoma of the bronchus.
    Crocker J; Ayres J; McGovern J
    Thorax; 1987 Dec; 42(12):972-5. PubMed ID: 2830683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified argyrophilic nucleolar organiser region (AgNOR) staining method for nucleolar staining in formalin-fixed, paraffin-embedded materials.
    Sato M; Chida T; Watanabe H; Noda Y; Ajioka Y; Katayama A; Abe M
    Gastroenterol Jpn; 1991 Jun; 26(3):391. PubMed ID: 1716235
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of staining of nucleolar organizer regions in cytological smears of the bronchus.
    Huang MS; Hwang JJ; Tsai MS; Wang TH; Lin MS; Chong IW; Tsai SY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Mar; 8(3):136-40. PubMed ID: 1373195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argyrophilic nucleolar organizer regions in benign and malignant mesothelial lesions.
    Vacharadze K; Burkadze G; Turashvili G; Kiria N
    Georgian Med News; 2005 Nov; (128):91-3. PubMed ID: 16369075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
    Arora B; Kumar S; Jain R
    J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleural biopsy in the diagnosis of malignant mesothelioma.
    Herbert A; Gallagher PJ
    Thorax; 1982 Nov; 37(11):816-21. PubMed ID: 7163999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on diagnostic value of analyzing argyrophilic nucleolar organizer regions in benign and malignant pleural effusions].
    Jiang S; Zeng Z; Liao Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):34-6. PubMed ID: 11263298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar organiser regions in normal, cirrhotic, and carcinomatous livers.
    Crocker J; McGovern J
    J Clin Pathol; 1988 Oct; 41(10):1044-8. PubMed ID: 2848058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.